IBS Subgroups For Lotronex Need Better Definition, Advisory Cmte. Says

The subgroup of irritable bowel syndrome patients for whom GlaxoSmithKline's Lotronex is most effective needs better definition, members of a joint FDA advisory committee meeting suggested